Emerging markets' dollar debt tops $4 trillion for first time, BIS says

By Marc Jones

LONDON, Oct 26 (Reuters) - Dollar-denominated debt in emerging markets has risen past $4 trillion for the first time following a surge in issuance during the COVID-19 crisis, data from the Bank for International Settlements (BIS) has shown.

The central bank umbrella group said a 14% jump in debt issuance during the April to June second quarter had driven a 7% year-on-year increase in broader dollar-denominated credit.

Dollar borrowing costs have fallen since the Federal Reserve slashed its interest rates to almost zero this year, but emerging markets are often warned of the "original sin" of being unable to repay dollar debt when their own currencies fall.

Consistent with the past few quarters, credit to Africa and the Middle East registered the highest growth rate at 14%, the BIS said, driven by countries in the Middle East.

Emerging Asia-Pacific and Latin America saw 9% and 5% respective year-on-year increases. In contrast, emerging Europe saw a 5% fall, extending the decline seen over the past six years as euro-denominated credit has become more important for the region.

Outstanding euro-denominated credit in emerging Europe, which includes countries such as Poland, Czech Republic, Hungary and Romania, surpassed dollar credit in terms of the overall amount earlier this year.

(Reporting by Marc Jones Editing by David Holmes)

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.